HAPBEE TECHNOLOGIES-SUB VTG (HAPB.CA) Stock News

Hapbee Unveils Revolutionary Digital Sleep Solution to Address the Global Sleep Crisis

VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the...

Hapbee Unveils Revolutionary Digital Sleep Solution to Address the Global Sleep Crisis

Mentions: -

Jumeirah Hotels Leads Hospitality Innovation with Launch of Hapbee Wellness Technology in Dubai

Luxury Hospitality Group to Offer Guests Customized Digital Sleep & Relaxation Featuring Hapbee Smart Sleep Pads and Immersive Mattress Toppers in Hotel...

Jumeirah Hotels Leads Hospitality Innovation with Launch of Hapbee Wellness Technology in Dubai

Luxury Hospitality Group to Offer Guests Customized Digital Sleep & Relaxation Featuring Hapbee Smart Sleep Pads and Immersive Mattress Toppers in Hotel Rooms and Spa

Mentions: -

Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors

Appointment indicates Hapbee’s commitment to expand in the Middle East and globally...

Hapbee Appoints Mr. Abdulla Al Zain to Board of Directors

Appointment indicates Hapbee’s commitment to expand in the Middle East and globally

Mentions: -

Hapbee Expands Retail Distribution with Target Stores

Hapbee Smart Sleep Pads Land in Additional Target Stores Nationwide Starting in October 2024...

Hapbee Expands Retail Distribution with Target Stores

Hapbee Smart Sleep Pads Land in Additional Target Stores Nationwide Starting in October 2024

Mentions: - TGT

Hapbee Announces Closing of Non-Brokered Private Placement

VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (the “Company” or “Hapbee”) (TSX-V: HAPB) (OTCQB: HAPBF) (FSE:...

Hapbee Announces Closing of Non-Brokered Private Placement

Mentions: -

Hapbee Announces Initial Closing of Non-Brokered Private Placement of $2.7 Million

MONTREAL, July 08, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the...

Hapbee Announces Initial Closing of Non-Brokered Private Placement of $2.7 Million

Mentions: -

Hapbee Announces Launch of Hapbee Experience At Irish Pub in Partnership with BodyTonic

Shareholders Elect Two New Directors Following Recent Annual General Meeting

Mentions: -

Hapbee Announces Launch of Hapbee Experience At Irish Pub in Partnership with BodyTonic

Shareholders Elect Two New Directors Following Recent Annual General Meeting...

Hapbee Announces Closing of Private Placement

Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing

Mentions: -

Hapbee Announces Closing of Private Placement

Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing...

Hapbee Announces Closing of Private Placement

Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing...

Hapbee Announces Closing of Private Placement

Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing

Mentions: -

Hapbee Received Commitments for $2.785 Million From Qualified Investors

Mentions: -

Hapbee Received Commitments for $2.785 Million From Qualified Investors

VANCOUVER, British Columbia, April 05, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the...

Hapbee Announces Closing of Private Placement

Hapbee Announces Closing of Private Placement Company Raises $2.8 Million From Qualified Investors...

Hapbee Announces Closing of Private Placement

Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing

Mentions: -

EMulate Therapeutics Named 50 Leading Companies of the Year for 2022 by The Silicon Review

BELLEVUE, WA / ACCESSWIRE / March 29, 2022 / EMulate Therapeutics, Inc., a clinical-stage digital therapeutics company, featured in The Silicon Review Magazine, titled "The Age of Digital Therapeutics is Upon Us." "…after many years of hard work and initial skepticism, our technology is at last ready for commercial presentation. Clinical results in patients with brain cancer are extremely encouraging, and recent pre-clinical results in

EMulate Therapeutics 2021 Year in Review - A Pivotal Year for the Company

2021 was the most productive year in the company's history, setting up 2022 for major advances. BELLEVUE, WA / ACCESSWIRE / February 1, 2022 / EMulate Therapeutics, Inc., a clinical-stage therapeutic device company focused on developing and commercializing innovative and distinctive therapies to address critical unmet needs in healthcare utilizing its proprietary radio frequency energy (RFE) technology focused at the ultra-low end of the RFE

Hapbee Collaborates with Deepak Chopra to Combine Its "Calm" Blend with Art, Sound and Meditation

Hapbee Adds 18 New Signal Blends in Major Expansion of Its Digital Wellness Platform

Hapbee Expands Leadership Team to Support Aggressive Growth Strategy

Hapbee Releases New "Boost" Signal to Help Users Energize Throughout the Day, Adding to its Expanding Library of Mood Signals

Hapbee Users Log Over 1 Million Hours of Use for Sleep, Focus and Alertness Signals

Hapbee Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO

Popular Wellness Wearable Band, Hapbee, Launches New Signal "Bedtime"

Hapbee Enters into Marketing Services Agreement with BMD Publishing